Keystone Symposia

This meeting took place in 2018

Here are the related meetings in 2020:
Microbiome: Therapeutic Implications (T1)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Microbiome, Host Resistance and Disease (X4)

Organizer(s) Wendy S. Garrett, Yasmine Belkaid and Janelle S. Ayres
March 4—8, 2018
Fairmont Banff Springs • Banff, AB Canada
Discounted Abstract Deadline: Nov 1, 2017
Abstract Deadline: Dec 1, 2017
Scholarship Deadline: Nov 1, 2017
Discounted Registration Deadline: Jan 9, 2018

Sponsored by Merck & Co., Inc.

Summary of Meeting:
The concept that the microbiome shapes health and susceptibility to disease has taken the biomedical sciences by storm. The microbiota is emerging as a fundamental force influencing diverse aspects of physiology reflected in the sessions of this conference. Microbiome studies are at a critical juncture and facing a challenging transition from descriptive studies of association towards mechanistic studies tackling causality. Essential for this transition is a diversity of thinking (chemical and systems biology, metabolism, microbiology, physiology and immunology) and approaches (assays and models). As the basic tools for characterizing microbiomes are now widely accessible, the conference seeks to broaden the base of what defines membership in microbiome studies by inviting investigators to share their vision, approach and results to enhance understanding and mechanistic approaches. In summary, the conference aims to: 1) Introduce a breadth of challenges and biological systems for microbiome studies; 2) Showcase young and senior investigators relevant to advancing next-gen microbiome studies; and 3) Foster collaborative, multidisciplinary microbiome research that advances basic and translational science.

View Meeting Program


Keystone Symposia Future of Science Fund Scholarship Recipients

Shai Bel
Bar-Ilan University, Israel

Nicholas Bessman
Weill Cornell Medicine, USA

Clarissa Campbell
Memorial Sloan Ketttering Cancer Center, USA

Michael G. Constantinides
NIAID, National Institutes of Health, USA

Kelsey E. Huus
University of British Columbia, Canada

Julia H. Kreznar
University of Wisconsin-Madison, USA

Brittany Needham
California Institute of Technology, USA

Jeffrey R. Singer
University of Alabama at Birmingham, USA

Zhenrun Jerry Zhang
Rockefeller University, USA